Torrent Pharma Recalls Over 27K Bottles Of Blood Pressure Lowering Drug In Us

The Affected Lot Has Been Produced In India And Later The Company Has Supplied To Its Us-Based Subsidiary For Distribution In The Us, The World'S Largest Market For Generic Drugs.Torrent Pharma Is Recalling More Than 27,000 Bottles Of Its Generic Drug, Used In Lowering High Blood Pressure, In The Us Market. As Per The Latest Enforcement Report By The Us Food And Drug Administration (Usfda), The Ahmedabad-Based Company Is Recalling 27,312 Bottles Of The Telmisartan And Hydrochlorothiazide Tablets. The Affected Lot Has Been Produced In India And Later The Company Has Supplied To ? Feature ? Medical Specialties ? Data & Analytics ? Brand Solutions ? ? 12/28/21, 10:18 Am Torrent Pharma Recalls Over 27K Bottles Of Blood Pressure Lowering Drug In Us, Pharma Torrent Pharma Usfda Health News Blood Pressure Its Us-Based Subsidiary For Distribution In The Us, The World'S Largest Market For Generic Drugs. According To The Us Health Regulator, The Drug Maker Is Recalling The Affected Lot Due To It Being "Superpotent; Hydrochlorothiazide." New Jersey-Based Torrent Pharma Inc, A Unit Of The Company, Has Initiated The Class Iii Nationwide (Us) Recall Of The 40 Mg/12.5 Mg, 30 Count Bottles On December 1, This Year. Telmisartan Hydrochlorothiazide Comprises Two Medicines, Both Of Which Help To Control High Blood Pressure. It Is Generally Used When One Medicine Alone Is Not Controlling The Blood Pressure Effectively. Lowering Blood Pressure Helps To Reduce Your Risk Of Having A Heart Attack Or A Stroke. As Per Usfda, A Class Iii Recall Is Initiated In A "Situation In Which Use Of, Or Exposure To, A Violative Product Is Not Likely To Cause Adverse Health Consequences." The Us Generic Drug Market Was Estimated To Be Around Usd 115.2 Billion In 2019. It Is The Largest Market For Pharmaceutical Products

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!